{
    "clinical_study": {
        "@rank": "151191", 
        "arm_group": [
            {
                "arm_group_label": "Metformin plus letrozole", 
                "arm_group_type": "Experimental", 
                "description": "metformin :850mg tablets twice daily for 6 months letrozole :5mg tablets twice daily form day 3to7 of cycle"
            }, 
            {
                "arm_group_label": "ovarian drilling", 
                "arm_group_type": "Experimental", 
                "description": "bilateral diathermy ovarian drilling, four drills each ovary"
            }
        ], 
        "brief_summary": {
            "textblock": "the study compare the hormonal-metabolic and reproductive outcome between combined\n      metformin-letrozole and ovarian drilling in clomiphene resistant women with polycystic\n      syndrome"
        }, 
        "brief_title": "Study to Compare Between Combimed Metformin-letrozole and Ovarian Drilling in Pcos With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian Syndrome", 
        "completion_date": {
            "#text": "July 2012", 
            "@type": "Actual"
        }, 
        "condition": "Focus of Study", 
        "condition_browse": {
            "mesh_term": "Polycystic Ovary Syndrome"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  polycystic ovary syndrome\n\n          -  infertility\n\n          -  clomiphene citrate resistance\n\n        Exclusion Criteria:\n\n          -  women with other causes of infertility as male factor or tubal factor, those with\n             endocrine disorders as thyroid dysfunction and hyperprolactinemia women who received\n             hormonal treatment or ovulation induction drugs 3 months prior to the study\n\n          -  pregnancy during follow up"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "146", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01693289", 
            "org_study_id": "elsharkwy t"
        }, 
        "intervention": [
            {
                "arm_group_label": "Metformin plus letrozole", 
                "intervention_name": "metformin plus letrozole", 
                "intervention_type": "Drug", 
                "other_name": "cidophage plus fumara"
            }, 
            {
                "arm_group_label": "ovarian drilling", 
                "intervention_name": "ovarian drilling", 
                "intervention_type": "Procedure", 
                "other_name": "ovarian dithermy drilling"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Clomiphene", 
                "Metformin", 
                "Letrozole"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Metformin", 
            "letrozole", 
            "ovarian drilling", 
            "clomiphene resistance", 
            "polycystic ovary."
        ], 
        "lastchanged_date": "September 25, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Zagazig", 
                    "country": "Egypt"
                }, 
                "name": "Zagazig University"
            }
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase 1 Study of Efficacy of Combined Metformin-letrozole in Comparison With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian Syndrome", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Egypt:Zagazig University"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "June 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "hormonal and metabolic changes", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01693289"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Zagazig University", 
            "investigator_full_name": "IBRAHIM ABD ELGAFOR", 
            "investigator_title": "obstetrics and gynecology department", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "reproductive outcome", 
            "safety_issue": "No", 
            "time_frame": "6months"
        }, 
        "source": "Zagazig University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Zagazig University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}